Covance Becomes SCRS Global Impact Partner

June 25, 2015
Applied Clinical Trials Editorial Staff

Applied Clinical Trials

The Society for Clinical Research Sites (SCRS) announced a two-year partnership with LabCorp.

 

The Society for Clinical Research Sites (SCRS) announced a two-year partnership with LabCorp. Under the agreement, Covance will participate as a Global Impact Partner (GIP), a relationship designed to facilitate dialogue between industry stakeholders and clinical research sites. As a GIP, Covance will participate on the SCRS Global Impact Board at an executive level, and work in tandem with SCRS’ Leadership Council in the development and execution of strategic initiatives for SCRS.

 

Read the full release here.